There is insufficient evidence to support exclusive enteral nutrition as an adjunctive therapy for active ulcerative colitis, ...
This new patient community provides medically reviewed content, connection, and support for people diagnosed with Crohn's disease or ulcerative colitis — all in Spanish. This is the second ...
Drinking two small glasses of cherry juice daily may help reduce gut inflammation and improve the quality of life for people ...
A CT scan confirmed Phoebe had suffered a stroke and she spent four days being tube-fed and bedridden. Tests later revealed ...
Swoop company MyHealthTeam has launched the Spanish-language patient community, MyCrohnsAndColitisTeam en español, designed to provide support, connection, and medically reviewed content for patients ...
Alvotech (NASDAQ:ALVOW – Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 9,400 shares, a ...
2d
Everyday Health on MSN9 Celebrities With Ulcerative Colitis Who’ve Spoken OutUlcerative colitis (UC) can affect anyone — even those in the spotlight. These 9 celebrities share their struggles and successes living with UC.
Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...
July 17, 2023 — Chronic inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, is on the rise worldwide. The benefits of current medications are limited by problematic ...
“Furthermore, these data strongly encourage us to pursue phase 2 clinical trials in other inflammatory indications including Crohn’s disease.” Ulcerative colitis is a debilitating ...
Protagonist Therapeutics, Inc.'s VERIFY and ANTHEM-UC studies show breakthroughs in polycythemia vera and ulcerative colitis.
STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results